ANCR LSE Week ended 31 Jul 2026

Weekly Investor Report

Animalcare Group plc · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data
Latest close 335.0 GBP
0.4% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 11.6% above the Trend Line and sits at 96.0% of its 52-week range. The latest completed week returned 0.4%, after a 0.4% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers. The latest news-sentiment score is 51/100. Near-term considerations: price is close to its 52-week high.

Setup score 69 out of 100
Latest Close 335.0 GBP 31 Jul 2026
1W Return 0.4% latest completed week
4W Return 0.4% short-term follow-through
12W Return 1.1% quarterly tape
Trend Breadth 55.8% 29 of 52 weeks active
Volume Ratio 2.4x vs 13-week average
What is working
  • The trend backdrop is active with a 16-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 32.93% based on similar historical setup states.
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.4% Latest completed week; four-week move 0.4%. Indicator stack 76/48 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 32.93% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 51/100 14 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 11.6% above the Trend Line and sits at 96.0% of its 52-week range. The latest completed week returned 0.4%, after a 0.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 2.4x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8612-week average 0.81

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.86Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 0.4% over four weeks, 1.1% over 12 weeks, and 25.0% over one year. The current trend has remained active for 16 consecutive weeks.

Performance by holding period

1W0.4%
4W0.4%
12W1.1%
26W18.4%
52W25.0%
Active trend streak16 weeks
Active weeks in one year29
Trend breadth55.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.21Latest activity-pressure read.
Pressure change-69.7%Four-week change in activity pressure.
Leadership11.41Latest relative-leadership reading.
RS change-12.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Dec 2025 Field coverage 91% Model confidence 72%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength18/100Blend of value, momentum, and quality. Underlying universe rank 83; rank 1 is best.
Value5/100Relative valuation strength. Underlying universe rank 96; rank 1 is best.
Quality17/100Profitability and accounting quality. Underlying universe rank 84; rank 1 is best.
Momentum89/100Medium-term price momentum. Underlying universe rank 12; rank 1 is best.
Growth15/100Revenue and earnings growth. Underlying universe rank 86; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework18/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
45.6x
Price divided by trailing earnings.
Price / sales
2.6x
Market value relative to trailing revenue.
EV / EBITDA
14.8x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
3.1%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
57.7%
Gross profit retained from each unit of revenue.
Operating margin
7.0%
Operating profit retained from revenue.
Free-cash-flow margin
8.5%
Free cash flow generated from revenue.
Return on invested capital
3.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
20.0%
Latest one-year revenue growth.
EPS growth
-72.6%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-9.4%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.7%
Cash dividends relative to market value.
Buyback yield
-0.0%
Net share repurchases relative to market value.
Shareholder yield
0.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment51/100

Weighted news tone is neutral across 14 relevant articles.

1 positive · 13 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-1.5%Distance below the 52-week high.
13-week volatility0.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 2610 weeks finished lower.
Best week+35.9%Week of 17 Apr.
Worst week-9.8%Week of 27 Mar.
Latest week+0.4%Week of 31 Jul.

Shape of recent returns

Strong gains2
Modest gains7
Flat weeks7
Modest losses8
Sharp losses2
Recent vol0.3%13-week weekly-return volatility.
Base vol5.8%52-week weekly-return volatility.
Up/down split17/19Count of positive and negative weeks in the 52-week window.
Average skew4.5% / -2.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape69/100

Trend, activity pressure, participation, and risk combine to a 69/100 tape read.

 Indicator analysis85/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.86; 2 reversal markers Next-Week ExpectancyNegative 32.93%

Next-week expectancy is negative with a 32.93% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors29/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 84; Small Cap Core rank 93 SVQF18/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 214.0 of 260 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment51/100

Weighted news tone is neutral across 14 relevant articles.

Charterhouse Capital Partners Completes Acquisition Of Animalcare Group Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026335.0 GBP0.4%300.1 GBP242.2 GBP0.2111.412.2MOn
24 Jul 2026333.5 GBP0.0%296.9 GBP241.2 GBP0.3912.381.3MOn
17 Jul 2026333.5 GBP0.0%293.7 GBP240.2 GBP0.6814.002.5MOn
10 Jul 2026333.5 GBP0.0%290.5 GBP239.3 GBP0.6815.051.1MOn
3 Jul 2026333.5 GBP0.6%287.3 GBP238.3 GBP0.6812.9918.6KOn
26 Jun 2026331.5 GBP0.0%284.5 GBP237.3 GBP0.6813.9748.8KOn
19 Jun 2026331.5 GBP0.0%281.7 GBP236.4 GBP0.7115.4129.0KOn
12 Jun 2026331.5 GBP0.0%279.0 GBP235.4 GBP0.7514.2620.2KOn
5 Jun 2026331.5 GBP-0.5%276.2 GBP234.4 GBP0.7915.4236.2KOn
29 May 2026333.0 GBP0.5%273.5 GBP233.5 GBP0.9115.35327.5KOn
22 May 2026331.5 GBP-0.2%270.7 GBP232.6 GBP1.0314.21595.0KOn
15 May 2026332.0 GBP0.2%268.0 GBP231.7 GBP1.1617.63775.1KOn
8 May 2026331.5 GBP-0.3%264.6 GBP230.7 GBP1.2317.373.3MOn
1 May 2026332.5 GBP0.0%261.3 GBP229.8 GBP0.7416.574.3MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context